Application
Western blot analysis of SPRED1 Antibody in Jurkat cell line lysates (35ug/lane). SPRED1 (arrow) was detected using the purified Pab.Application
SPRED1 Antibody flow cytometry analysis of Jurkat cells (bottom histogram) compared to a negative control cell (top histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.| Product Name | SPRED1 Antibody |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | SPRED1; Sprouty-related, EVH1 domain-containing protein 1 |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WBFC |
| WB:1:100~500 FC |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Alternative Names | SPRED1 Sprouty-related EVH1 domain-containing protein 1 |
|---|---|
| Molecular Weight(MW) | 50477 Da |
| Function | Tyrosine kinase substrate that inhibits growth-factor- mediated activation of MAP kinase. Negatively regulates hematopoiesis of bone marrow (By similarity) |
| Tissue Specificity | Weakly expressed in embryonic cell line HEK293 |
| Cellular Localization | Cell membrane; Peripheral membrane protein. Membrane, caveola; Peripheral membrane protein. Nucleus Note=Localized in cholesterol-rich membrane raft/caveola fractions |
| Entrez Gene | 161742 |
|---|
Application
Western blot analysis of SPRED1 Antibody in Jurkat cell line lysates (35ug/lane). SPRED1 (arrow) was detected using the purified Pab.
Application
SPRED1 Antibody flow cytometry analysis of Jurkat cells (bottom histogram) compared to a negative control cell (top histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.| Application Notes | WB:1:100~500 FC |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
